↓ Skip to main content

The Potential Benefits of HPV E6/E7 mRNA Test in Cervical Cancer Screening in China

Overview of attention for article published in Frontiers in oncology, October 2020
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (62nd percentile)
  • High Attention Score compared to outputs of the same age and source (83rd percentile)

Mentioned by

policy
1 policy source
twitter
1 X user

Citations

dimensions_citation
17 Dimensions

Readers on

mendeley
19 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
The Potential Benefits of HPV E6/E7 mRNA Test in Cervical Cancer Screening in China
Published in
Frontiers in oncology, October 2020
DOI 10.3389/fonc.2020.533253
Pubmed ID
Authors

Shao-Kai Zhang, Zhen Guo, Peng Wang, Le-Ni Kang, Man-Man Jia, Ze-Ni Wu, Qiong Chen, Xiao-Qin Cao, Dong-Mei Zhao, Pei-Pei Guo, Xi-Bin Sun, Jian-Gong Zhang, You-Lin Qiao

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 19 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 19 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 4 21%
Researcher 3 16%
Student > Doctoral Student 2 11%
Student > Master 2 11%
Student > Postgraduate 1 5%
Other 0 0%
Unknown 7 37%
Readers by discipline Count As %
Medicine and Dentistry 5 26%
Biochemistry, Genetics and Molecular Biology 2 11%
Nursing and Health Professions 2 11%
Immunology and Microbiology 1 5%
Unknown 9 47%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 August 2023.
All research outputs
#7,779,278
of 26,549,961 outputs
Outputs from Frontiers in oncology
#2,799
of 23,253 outputs
Outputs of similar age
#158,733
of 438,754 outputs
Outputs of similar age from Frontiers in oncology
#106
of 686 outputs
Altmetric has tracked 26,549,961 research outputs across all sources so far. This one has received more attention than most of these and is in the 69th percentile.
So far Altmetric has tracked 23,253 research outputs from this source. They receive a mean Attention Score of 3.2. This one has done well, scoring higher than 87% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 438,754 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 62% of its contemporaries.
We're also able to compare this research output to 686 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 83% of its contemporaries.